���Ҵ�ý�ƽ������

Colorado BioScience Association (CBSA)—Colorado BioScience Association (CBSA) has announced the presenting companies selected for the 2026 Rocky Mountain Life Sciences Investor & Partnering Conference Presented by BioMed Realty, bringing a powerful cross-section of high-growth life sciences opportunities to investors and strategic partners in Vail, Sept. 30-Oct. 2, 2026. The lineup features close to 50 companies from Colorado and the Rocky Mountain West, including eight from ���Ҵ�ý�ƽ������.

The conference highlights investment-ready companies and creates opportunities to build relationships that help companies grow, scale and succeed.

���Ҵ�ý�ƽ������ Companies

Funding Sought: $3M Seed

Illumen Therapeutics, is pursuing a novel therapeutic strategy to treat aggressive cancers, such as colorectal and pancreatic cancers, by restoring functional p53 through inhibiting the enzyme PARN. This breakthrough in oncology drug development avoids the historical problems exhibited with MDM2 inhibitors. Read ���Ҵ�ý�ƽ������ Their CU Connection

��

Funding Sought: $4M Seed

Renovare Therapeutics is a biotechnology company developing��a pipeline of regenerative therapies for osteoarthritis (OA), a disease impacting 500 million patients globally with no disease-modifying treatments available. Their technology spans advanced particle drug delivery, regenerative biomaterials and engineered��gene therapy, allowing us to address��the full disease spectrum. Read ���Ҵ�ý�ƽ������ Their CU Connection

Think Bioscience��is a privately held small molecule drug discovery company based in Boulder, Colorado, focused on developing therapeutics against targets that have historically been considered “undruggable”. The company’s team combines expertise in synthetic biology, protein biophysics, applied enzymology, computational chemistry and medicinal chemistry to launch a first-in-class program for diseases with high unmet need. Read ���Ҵ�ý�ƽ������ Their CU Connection

VitriVax is a Boulder, Colorado-based biotechnology company advancing the ALTA® (Atomic Layering Thermostable Antigen and Adjuvant) platform, a novel technology designed to overcome key challenges in vaccine delivery. ALTA® combines thermostabilization and controlled-release technologies to protect vaccine components from degradation and enable programmable antigen release over time. The platform has the potential to eliminate cold-chain requirements, reduce multi-dose vaccination schedules to a single administration and support the co-formulation of multiple vaccine components in a single product. Read ���Ҵ�ý�ƽ������ Their CU Connection

Flari

Flari is building a breath analysis platform based on cutting-edge quantum sensing technologies that represent a new category of analytical methods for studying molecular biology and metabolomics. This platform can support research and development as well as test development and implementation. It promises to broaden testing options for a wide variety of diseases and monitoring needs. Read ���Ҵ�ý�ƽ������ Their CU Connection

Funding Sought: $5M Seed

TissueForm has developed Allovia™, a flowable implant for repairing cartilage defects that provides immediate structural support. Made from natural materials derived from human cartilage tissue, Allovia is an off-the-shelf, resorbable implant designed to support the body’s natural healing response in the knee. Read ���Ҵ�ý�ƽ������ Their CU Connection

Funding Sought: $2.75M Seed

Transformative Biotech is transforming PCR testing for infectious diseases with patented direct-to-PCR platform technologies. Clinically validated on more than 590,000 patient samples, our platform enables rapid, accurate and affordable molecular testing. @ANYWHERE™, our smartphone-powered handheld PCR platform in development, is designed to expand access to testing, accelerate treatment and reduce the spread of infectious diseases worldwide, ultimately saving lives.

Funding Sought: $5M Seed

VitaWave Tech is developing eBP, a clinical-grade, in-ear blood pressure monitor that delivers FDA AAMI-compliant accuracy with the ease of an earbud. Targeting hypertension, preeclampsia and chronic kidney disease patients, eBP enables remote patient monitoring through a connected mobile app and provider portal with EHR integration. Read ���Ҵ�ý�ƽ������ Their CU Connection